Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site

Racial and Ethnic Differences in Youth Hallucinogen Use

The NHSDA Report:  Racial and Ethnic Differences in Youth Hallucinogen Use

 

Highlights:

  • Hallucinogens include LSD, PCP, MDMA (Ecstasy), peyote, mescaline, and psilocybin (mushrooms).
  • Based on SAMHSA's National Household Survey on Drug Abuse, in 2001 almost 1.4 million youth aged 12 to 17 had used hallucinogens at least once in their lifetime.
  • Among youth, Blacks were less likely than whites, Asians, or Hispanics to have used any hallucinogen in their lifetime.
  • Blacks and Hispanics were more likely than whites and Asians to perceive great risk in trying LSD once or twice.

Reports on Racial & Ethnic Groups

Reports on Youth

Reports on Hallucinogens

Reports on Other Drugs

Other Topics

This Short Report,  The NHSDA Report:  Racial and Ethnic Differences in Youth Hallucinogen Use, is based on SAMHSA's  National Household Survey on Drug Abuse (NHSDA), conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  SAMHSA's National Household Survey on Drug Abuse (NHSDA) is the primary source of information on the prevalence, patterns, and consequences of drug and alcohol use and abuse in the general U.S. civilian non institutionalized population, aged 12 and older.   The NHSDA also provides estimates for drug use by state.

This is the page footer.

This page has been accessed 62497 times since 8/14/03.

This page was last updated on March 16, 2008.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

Yellow Line

Site Map | Contact Us | Accessibility Privacy PolicyFreedom of Information ActDisclaimer  |  Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* Adobe™ PDF and MS Office™ formatted files require software viewer programs to properly read them. Click here to download these FREE programs now

What's New

Highlights Topics Data Drugs Pubs Short Reports Treatment Help Mail OAS